
02 April 2026Publication
VAT and price rebates
Payments by a manufacturer of medicines to the UK government did not qualify as price reductions of earlier supplies to wholesalers and pharmacies
Healthcare and life science businesses trust us for our in-depth knowledge of this highly-regulated sector. And because our integrated teams deliver exceptional technical expertise and service.
Our global team is dedicated to the full legal scope of healthcare and life sciences, including intellectual property, product liability, competition/antitrust, tax, corporate, employment, investment and finance.
We provide a single source of expert advice across the sector, collaborating closely between practices and across our international network.
That’s why our clients include 18 of the world’s top 20 pharmaceutical companies, global medical device manufacturers, household-name consumer brands, healthcare services businesses and innovative startups
We’re especially active in the world of digital health, combining our experience in both healthcare and technology.
We take pride in delivering exceptional service to our clients. Secondments give our team invaluable experience and insight, and help us to help you plan for future growth. We’re also actively involved with trade associations like EFPIA, and the national associations wherever we work across the world.
The result: comprehensive, consistently high-quality advice. Not just on the details of healthcare legislation, but on commercial strategies for driving your business forward.
If you have any questions, contact a member of the Healthcare and Life Sciences team for assistance:

02 April 2026Publication
Payments by a manufacturer of medicines to the UK government did not qualify as price reductions of earlier supplies to wholesalers and pharmacies

01 April 2026 Publication
This three-part podcast series explores the rapidly evolving UK regulatory landscape governing the advertising of foods high in fat, salt and sugar (HFSS)

31 March 2026 Publication
The High Court finds ex-employees misused confidential information and trade secrets, offering lessons on managing confidentiality risks.

27 March 2026 Publication
The EU’s digital regulatory landscape is evolving at unprecedented speed, creating both new compliance challenges and strategic opportunities in Europe

27 March 2026 Publication
In this podcast, we discuss the challenges of cross-border trading and investing in an increasingly fragmented geopolitical and economic landscape.